Yahoo
SES - Delayed Quote SGD

Embracing Future Holdings Limited (8YY.SI)

0.0240 0.0000 (0.00%)
At close: November 2 at 5:04:18 PM GMT+8
Chart Range Bar
Loading chart for 8YY.SI
  • Previous Close 0.0240
  • Open 0.0240
  • Bid 0.0240 x --
  • Ask 0.0260 x --
  • Day's Range 0.0240 - 0.0240
  • 52 Week Range 0.0210 - 0.0920
  • Volume 63,700
  • Avg. Volume 407,964
  • Market Cap (intraday) 41.603M
  • Beta (5Y Monthly) 0.79
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Singapore, China, and Hong Kong. It operates through Cancer, Infectious Diseases, E-Sports, and Advertising segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CTCs from leukocytes. It also engages in technology development, technology transfer, marketing, sale and distribution of biomedical technology, life and medicine science related products and services, integrated marketing services provider in the gaming industry, multi-channel networking and live-streaming and investment activities. The company was formerly known as Biolidics Limited and changed its name to Embracing Future Holdings Limited in June 2025. Embracing Future Holdings Limited was incorporated in 2009 and is based in Singapore.

www.ebfholdings.com

16

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is STI Index (^STI) .

YTD Return

8YY.SI
53.85%
STI Index (^STI)
14.15%

1-Year Return

8YY.SI
4.35%
STI Index (^STI)
19.76%

3-Year Return

8YY.SI
100.00%
STI Index (^STI)
72.06%

5-Year Return

8YY.SI
86.44%
STI Index (^STI)
64.08%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -44.71%

  • Return on Assets (ttm)

    -36.26%

  • Return on Equity (ttm)

    -208.26%

  • Revenue (ttm)

    6.82M

  • Net Income Avi to Common (ttm)

    -3.05M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    494k

  • Total Debt/Equity (mrq)

    152.50%

  • Levered Free Cash Flow (ttm)

    -1.28M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: